- Home
- DDS vs LEGN Comparison
DDS vs LEGN Comparison
Compare DDS & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDS
- LEGN
- Stock Information
- Founded
- DDS 1938
- LEGN 2014
- Country
- DDS United States
- LEGN United States
- Employees
- DDS N/A
- LEGN N/A
- Industry
- DDS Department/Specialty Retail Stores
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- DDS Consumer Discretionary
- LEGN Health Care
- Exchange
- DDS Nasdaq
- LEGN Nasdaq
- Market Cap
- DDS 7.0B
- LEGN 7.8B
- IPO Year
- DDS N/A
- LEGN 2020
- Fundamental
- Price
- DDS $436.85
- LEGN $34.68
- Analyst Decision
- DDS Sell
- LEGN Strong Buy
- Analyst Count
- DDS 2
- LEGN 13
- Target Price
- DDS $324.00
- LEGN $81.54
- AVG Volume (30 Days)
- DDS 133.9K
- LEGN 1.5M
- Earning Date
- DDS 11-14-2024
- LEGN 11-12-2024
- Dividend Yield
- DDS 5.96%
- LEGN N/A
- EPS Growth
- DDS N/A
- LEGN N/A
- EPS
- DDS 38.87
- LEGN N/A
- Revenue
- DDS $6,697,476,000.00
- LEGN $520,183,000.00
- Revenue This Year
- DDS N/A
- LEGN $120.77
- Revenue Next Year
- DDS $0.41
- LEGN $68.54
- P/E Ratio
- DDS $11.22
- LEGN N/A
- Revenue Growth
- DDS N/A
- LEGN 122.96
- 52 Week Low
- DDS $328.00
- LEGN $32.66
- 52 Week High
- DDS $476.48
- LEGN $70.13
- Technical
- Relative Strength Index (RSI)
- DDS 52.25
- LEGN 32.71
- Support Level
- DDS $415.44
- LEGN $40.97
- Resistance Level
- DDS $471.78
- LEGN $43.96
- Average True Range (ATR)
- DDS 16.45
- LEGN 2.03
- MACD
- DDS -4.07
- LEGN -0.72
- Stochastic Oscillator
- DDS 38.00
- LEGN 16.97
About DDS Dillard's Inc.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.